The Vaccine Contract Development and Manufacturing Organization (CDMO) market is a rapidly evolving segment within the broader biopharmaceutical industry. As vaccine development becomes increasingly complex, both technologically and logistically, pharmaceutical companies are relying more heavily on CDMOs to streamline production, enhance flexibility, and reduce time-to-market. Vaccine CDMOs...